ComfortDelGro Corporation Australia Pty Ltd agreed to acquire A2B Australia Limited (ASX:A2B) for AUD180 million on December 22, 2023. A2B?s Board has carefully considered the Scheme, and each member of the A2B Board considers that the Scheme is in the best interests of A2B shareholders and recommends that A2B shareholders vote in favor of the Scheme. conditions for Implementation of the Scheme include A2B shareholder approval; Court approval; ASIC and ASX approval; applicable regulatory consents, including clearance from the ACCC; no Material Adverse Effect, as defined in the SIA; no A2B Prescribed Events, as defined in the SIA; and the Independent Expert concluding (and continuing to conclude) that the Scheme is in the best interests of A2B shareholders.

The Scheme is not subject to any financing condition. Transaction will be funded through existing cash and bank facilities. A2B is being advised by MA Moelis Australia Pty Ltd as financial advisor and King & Wood Mallesons as legal advisor.

ComfortDelGro Corporation Australia Pty Ltd appointed Grant Samuel and Corrs Chambers Westgarth as its financial and legal advisors respectively for the Proposed Transaction. As of February 27, 2024, ACCC condition contained in the Scheme Implementation Agreement between CDC and A2B dated 22 December 2023 has therefore been satisfied.